Isolated hepatic perfusion for metastatic melanoma

Area of Science:

• Oncology
• Surgical Oncology
• Hepatobiliary Surgery

Background:

• Unresectable hepatic metastases from melanoma pose significant treatment challenges.
• Systemic therapies for metastatic cutaneous melanoma to the liver show limited efficacy.
• Prognosis is particularly poor for patients with metastatic ocular melanoma to the liver.

Purpose of the Study:

• To evaluate isolated hepatic perfusion as a treatment option for unresectable hepatic melanoma metastases.
• To assess the feasibility of delivering high-dose chemotherapy directly to the liver while minimizing systemic exposure.

Main Methods:

• Isolated hepatic perfusion, performed either open or percutaneously.
• Direct delivery of high-dose cytotoxic chemotherapy to the liver.

Main Results:

• Isolated hepatic perfusion allows for targeted chemotherapy delivery to the liver.
• Minimizes systemic exposure to cytotoxic agents.
• Emerges as a viable treatment option for complex patient cases.

Conclusions:

• Isolated hepatic perfusion is a promising approach for managing unresectable hepatic melanoma metastases.
• Offers a method to intensify liver-directed therapy.
• Represents an advancement in treating challenging liver-dominant melanoma.